SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-103960
Filing Date
2020-09-10
Accepted
2020-09-10 16:25:57
Documents
18
Period of Report
2020-09-09
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2030337-6_8k.htm   iXBRL 8-K 29934
2 EXHIBIT 1.1 tm2030337d6_ex1-1.htm EX-1.1 280751
3 EXHIBIT 5.1 tm2030337d6_ex5-1.htm EX-5.1 10526
4 EXHIBIT 99.1 tm2030337d6_ex99-1.htm EX-99.1 9336
5 GRAPHIC tm2030337d6_ex5-1img001.jpg GRAPHIC 3590
6 GRAPHIC tm2030337d6_ex5-1img003.jpg GRAPHIC 10009
7 GRAPHIC tm2030337d6_ex5-1img002.jpg GRAPHIC 2069
  Complete submission text file 0001104659-20-103960.txt   600917

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA albo-20200507.xsd EX-101.SCH 3201
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE albo-20200507_lab.xml EX-101.LAB 34591
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE albo-20200507_pre.xml EX-101.PRE 22720
11 EXTRACTED XBRL INSTANCE DOCUMENT tm2030337-6_8k_htm.xml XML 3585
Mailing Address 10 POST OFFICE SQUARE SUITE 502 SOUTH BOSTON MA 02109
Business Address 10 POST OFFICE SQUARE SUITE 502 SOUTH BOSTON MA 02109 857-415-4774
ALBIREO PHARMA, INC. (Filer) CIK: 0001322505 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33451 | Film No.: 201168924
SIC: 2834 Pharmaceutical Preparations